“…PKA is a heterotetrameric holoenzyme in which two catalytic subunits from two major families, Cα and Cβ (plus a third, rarer Cγ isoform) combine with homodimers formed by any of four R-subunits (RIα, RIβ, RIIα, RIIβ) to form a number of distinct, functionally nonredundant R2:C2 holoenzymes ( Taylor et al, 2004 ; Taylor et al, 2005 ; Taylor et al, 2013 ; Taylor et al, 2022 ). Classically, however, two main subtypes of PKA are specified by the inclusion of either RI or RII regulatory subunits, each having nearly ubiquitous expression, but distinct allosteric properties, anchoring, and cellular localization, as expertly and extensively reviewed elsewhere ( Taylor et al, 2013 ; Turnham and Scott, 2016 ; Gold, 2019 ; Michel and Scott, 2022 ; Taylor et al, 2022 ). Canonically, PKA is activated when cAMP binds to the regulatory subunits triggering release of the catalytic subunits [though recent work has challenged this cAMP gated free-release dogma ( Smith et al, 2013 ; Smith et al, 2017 ; Isensee et al, 2018 )] as reviewed in ( Gold, 2019 ).…”